Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17β-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study

Fertility and Sterility

Volumn 88, Issue 2, 2007, Pages 383-389

  Castelo Branco, Camil ^a   Palacios, Santiago ^b   Vázquez, Francisco ^c   Villero, José ^d   Ferrer, Javier ^e   Ascaso, Carlos ^f   Balasch, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Instituto Palacios de Salud Y Medicina de la Mujer   (Spain)

^c Centro de Estudios de Obstetricia Y Ginecología Asociado   (Spain)

^d Obstetrics and Gynecology Department   (Argentina)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

Author keywords

body mass index; estradiol; Intranasal hormone therapy; leptin; lipid profile; menopause

Indexed keywords

CHOLESTEROL; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NORETHISTERONE; PLACEBO; S 21405; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADMINISTRATION, INTRANASAL; ADULT; AGED; BODY MASS INDEX; CONTRACEPTIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LEPTIN; LIPIDS; MIDDLE AGED; NORETHINDRONE; PLACEBOS; POSTMENOPAUSE;

EID: 34547818649     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.142     Document Type: Article

References (47)

1. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 273 (1995) 199-208
2. Gambacciani M., Ciaponi M., Cappagli B., Piaggesi L., De Simone L., Orlandi R., and Genazzani A.R. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 82 (1997) 414-417
3. Gambacciani M., Ciaponi M., Cappagli B., De Simone L., Orlandi R., and Genazzani A.R. Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. Maturitas 39 (2001) 125-132
4. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., et al. Serum immunoreactive leptin concentrations in normal-weight and obese women. N Engl J Med 334 (1996) 292-295
5. Ahima R., and Osei S. Molecular regulation of eating behavior: new insights and prospects for therapeutic strategies. Trends Mol Med 7 (2001) 205-213
6. Di Carlo C., Tommaselli G.A., and Nappi C. Effects of sex steroid hormones and menopause on serum leptin concentrations. Gynecol Endocrinol 16 (2002) 479-492
7. Thomas T., Burguera B., Melton III L.J., Atkinson E.J., O'Fallon W.M., Riggs B.L., and Khosla S. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 49 (2000) 1278-1284
8. Hadji P., Hars O., Bock K., Sturm G., Bauer T., Emons G., and Schulz K.D. The influence of menopause and body mass index on serum leptin concentrations. Eur J Endocrinol 143 (2000) 55-60
9. Kanaley J.A., Sames C., Swisher L., Swick A.G., Ploutz-Snyder L.L., Steppan C.M., et al. Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status. Metabolism 50 (2001) 976-982
10. Kristensen K., Pedersen S.B., and Richelsen B. Interactions between sex steroid hormones and leptin in women. Studies in vivo and in vitro. Int J Obes Relat Metab Disord 24 (2000) 1438-1444
11. Havel P.J., Kasim-Karakas S., Dubuc G.R., Mueller W., and Phinney S.D. Gender differences in plasma leptin concentrations. Nat Med 2 (1996) 949-950
12. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., et al. Leptin levels in human and rodent: measurements of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1 (1995) 1155-1161
13. Hassink S.G., Sheslow D.V., de Lancey E., Opentanova I., Considine R.V., and Caro J.F. Serum leptin in children with obesity: relationship to gender and development. Pediatrics 98 (1996) 201-203
14. Shimizu H., Shimomura Y., Nakanishi Y., Futawatari T., Ohtani K., Sato N., and Mori M. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 154 (1997) 285-292
15. Brann D.W., De Sevilla L., Zamorano P.L., and Malesh V.B. Regulation of leptin gene expression and secretion by steroid hormones. Steroids 64 (1999) 659-663
16. Machinal-Quelin F., Dieudonne M.N., Pecquery R., Leneveu M.C., and Giudicelli Y. Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue. Endocrine 18 (2002) 179-184
17. Espeland M.A., Stefanick M.L., Kritz-Silverstein D., Fineberg S.E., Waclawiw M.A., James M.K., and Greendale G.A. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab 82 (1997) 1549-1556
18. Sorensen M.B., Rosenfalck A.M., Hojgaard L., and Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res 9 (2001) 622-626
19. Hassager C., and Christiansen C. Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women. Metabolism 38 (1989) 662-665
20. Haarbo J., Marslew U., Gotfredsen A., and Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40 (1991) 1323-1326
21. Bartness T.J., and Wade G.N. Effects of interscapular brown adipose tissue denervation on body weight and energy metabolism in ovariectomized and estradiol-treated rats. Behav Neurosci 98 (1984) 674-685
22. Stern J.J., and Murphy M. The effects of thyroxine and estradiol benzoate on wheel running activity in female rats. Physiol Behav 9 (1972) 79-82
23. Wade G.N., and Gray J.M. Gonadal effects on food intake and adiposity: a metabolic hypothesis. Physiol Behav 22 (1979) 583-593
24. Dagnault A., Ouerghi D., and Richard D. Treatment with alpha-helical-CRF(9-41) prevents the anorectic effect of 17-beta-estradiol. Brain Res Bull 32 (1993) 689-692
25. Baranowska B., Radzikowska M., Wasilewska-Dziubinska E., Roguski K., and Polonowski A. Relationship among leptin, neuropeptide Y, and galanin in young women and in postmenopausal women. Menopause 7 (2000) 149-155
26. Di Carlo C., Tommaselli G.A., Pisano G., Nasti A., Rossi V., Palomba S., and Nappi C. Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy. Menopause 7 (2000) 36-41
27. Haffner S.M., Mykkanen L., and Stern M.P. Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy. Am J Epidemiol 146 (1997) 581-585
28. Rosenbaum M., Nicolson M., Hirsch J., Heymsfield S.B., Gallagher D., Chu F., and Leibel R.L. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 81 (1996) 3424-3427
29. Ayub N., Khan S.R., and Syed F. Leptin levels in pre and post menopausal Pakistani women. J Pak Med Assoc 56 (2006) 3-5
30. Hadji P., Gorke K., Hars O., Bauer T., Emons G., and Schulz K.D. The influence of hormone replacement therapy (HRT) on serum leptin concentration in postmenopausal women. Maturitas 37 (2000) 105-111
31. Konukoglu D., Serin O., and Ercan M. Plasma leptin levels in obese and non-obese postmenopausal women before and after hormone replacement therapy. Maturitas 36 (2000) 203-207
32. Messinis I.E., Kariotis I., Milingos S., Kollios G., and Seferiadis K. Treatment of normal women with oestradiol plus progesterone prevents the decrease of leptin concentrations induced by ovariectomy. Hum Reprod 15 (2000) 2383-2387
33. Messinis I.E., Papageorgiou I., Milingos S., Asprodini E., Kollios G., and Seferiadis K. Oestradiol plus progesterone treatment increases serum leptin concentrations in normal women. Hum Reprod 16 (2001) 1827-1832
34. Lavoie H.B., Taylor A.E., Sharpless J.L., Anderson E.J., Strauss C.C., and Hall J.E. Effects of short-term hormone replacement on serum leptin levels in postmenopausal women. Clin Endocrinol 5 (1999) 415-422
35. Cagnacci A., Malmusi S., Arangino S., Zanni A., Rovati L., Cagnacci P., and Volpe A. Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study. Menopause 9 (2002) 65-71
36. Wade G.N., and Gray J.M. Cytoplasmic 17-beta [3H] estradiol binding in rat adipose tissues. Endocrinology 103 (1978) 1695-1701
37. Castracane V.D., Kraemer R.R., Franker M.A., Kraemer G.R., and Gimpel T. Serum leptin concentration in women: effect of age, obesity, and estrogen administration. Fertil Steril 70 (1998) 472-477
38. Paolisso G., Rizzo M.R., Mone C.M., Tagliamonte M.R., Gambardella A., Riondino M., et al. Plasma sex hormones are significantly associated with plasma leptin concentration in healthy subjects. Clin. Endocrinol 48 (1998) 291-297
39. Vettor R., De Pergola G., Pagano C., Englaro P., Laudadio E., Giorgino F., et al. Gender differences in serum leptin in obese people: relationship with testosterone, body fat distribution and insulin sensitivity. Eur J Clin Invest 27 (1997) 1016-1024
40. Nagy T.R., Davies S.L., Hunter G.R., Darnell B., and Weinsier R.L. Serum leptin concentrations and weight gain in obese postmenopausal women. Obes Res 6 (1998) 257-261
41. Auverix J., and Staels B. Leptin. Lancet 351 (1999) 737-742
42. Ostlund R.E., Yang J.W., Klein S., and Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age and metabolic covariates. J Clin Endocrinol Metab 81 (1996) 3909-3913
43. Kiran H., Kiran G., Ekerbicer H.C., and Kilinc M. Effects of intranasal estradiol treatment on serum lipoprotein(a) and lipids in hysterectomized women. Gynecol Obstet Invest 57 (2004) 191-195
44. Hemelaar M., Kenemans P., de Bie L., van de Weijer P.H., and van der Mooren M.J. Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women. Fertil Steril 85 (2006) 979-988
45. Mattsson L.A., Christiansen C., Colau J.C., Palacios S., Kenemans P., Bergeron C., et al. Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms. Am J Obstet Gynecol 182 (2000) 545-552
46. Godsland I.F. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations analysis of studies published from 1974-2000. Fertil Steril 75 (2001) 898-915
47. Sitruk-Ware R. Progestins and cardiovascular risk markers. Steroids 65 (2000) 651-658